Measles Post-Exposure Prophylaxis: Timing of Immunoglobulin and Vaccine Administration
Post-Exposure Vaccine Administration
For immunocompetent individuals ≥6 months old exposed to measles, administer MMR vaccine within 72 hours of exposure as the preferred post-exposure prophylaxis. 1 This approach provides active immunity and is more practical than immunoglobulin for most settings including daycare, schools, and healthcare facilities.
Key Timing Points for Vaccine:
- 72-hour window: Vaccine may provide protection if given within 3 days of initial exposure 1
- Infants 6-11 months receiving early vaccination must be revaccinated with 2 doses after their first birthday (at 12-15 months and 4-6 years) 1
- Post-exposure vaccination does not increase adverse event risk even if given during presymptomatic or prodromal illness 1
Immunoglobulin for Post-Exposure Prophylaxis
When to Use IG Instead of Vaccine:
Immunoglobulin is indicated when vaccine is contraindicated or when exposure is recognized >72 hours after initial contact. 1 This includes:
- Infants <6 months (now including birth to 6 months per updated guidance) 2
- Pregnant women without measles immunity
- Immunocompromised persons (severely immunosuppressed or symptomatic HIV-infected)
- Susceptible household contacts not vaccinated within 72 hours
IG Dosing by Population:
Standard immunocompetent individuals:
Immunocompromised persons:
- 0.5 mL/kg IM (maximum 15 mL) 1
- Corresponds to approximately 82.5 mg/kg IgG protein 1
- Alternative: 400 mg/kg IVIG for severely immunocompromised or when injection volume is prohibitive 3, 4
Infants <6 months:
IVIG Recipients:
Patients receiving regular IVIG (100-400 mg/kg) may not need additional IG if exposure occurs within 3 weeks of their last IVIG dose 1
Critical Spacing: Vaccine After Immunoglobulin
This is where timing becomes absolutely critical to avoid vaccine failure due to passive antibody interference.
Standard IG Dose (0.25 mL/kg IM):
Wait 5-6 months before administering MMR vaccine 1
High-Dose IG (0.5 mL/kg IM for immunocompromised):
The evidence suggests longer intervals are needed with higher doses. While the 1998 ACIP guidelines specify 5-6 months for standard doses 1, research on higher doses indicates:
- Wait at least 9 months after 4 g/kg total IVIG exposure 5
- Antibody titers remained positive at 6 months but were negative by 9 months 5
IVIG Dosing (400 mg/kg):
Wait 8-11 months before MMR vaccination based on the dose administered:
- Standard IVIG (100-400 mg/kg): approximately 8-11 months 6
- The U.S. recommendation of 11 months for 2 g/kg may be longer than necessary, but provides safety margin 5
Practical Algorithm for Vaccine Timing After IG:
- Standard IG (0.25 mL/kg IM): Wait 5-6 months
- High-dose IG (0.5 mL/kg IM): Wait 6-9 months (lean toward 9 months for certainty)
- IVIG 400 mg/kg: Wait 8-11 months
- IVIG 2 g/kg (e.g., Kawasaki disease): Wait 11 months per U.S. guidelines, though 9 months may suffice 5
Critical Pitfalls to Avoid:
⚠️ Do not assume all IG products have equivalent measles antibody titers - concentrations have declined over time as vaccine-derived immunity predominates in donor populations 3, 4
⚠️ Do not give vaccine too soon after IG - passively acquired antibodies will interfere with active immune response, requiring revaccination 1
⚠️ Do not forget to revaccinate infants who received early measles vaccine (<12 months) - they need 2 additional properly-spaced doses 1
⚠️ For persons on regular IVIG therapy - MMR vaccine should be given at least 2 weeks BEFORE starting IVIG if possible, as ongoing therapy will continuously interfere with vaccine response 1
Special Populations:
HIV-infected persons:
- Those without severe immunosuppression should receive MMR vaccine at least 2 weeks before starting IVIG therapy 1
- If exposed to measles while on IVIG, they need IG prophylaxis regardless of vaccination status 1
Pregnant women: